Reconstruct before escalating
Make every prior treatment trial clinically interpretable
Complex treatment planning begins with a reliable timeline: target symptoms, medication and psychotherapy exposure, dose and duration, actual use, benefit, adverse effects, reasons for stopping, monitoring, and functional change. This review often reveals modifiable barriers and prevents unnecessary polypharmacy.
- Practice context
- Specialty outpatient, consultation, inpatient, collaborative care, and interventional psychiatry settings
- Typical pace
- Deliberate longitudinal reassessment with closer follow-up during medication changes, safety concerns, or advanced treatment initiation
- Who's involved
- People with persistent symptoms, recurrent episodes, uncertain prior response, medication intolerance, complex comorbidity, or high-risk medication regimens
Common presentations
- Persistent depression, mania, psychosis, anxiety, or trauma-related symptoms
- Multiple prior medication trials with incomplete or conflicting documentation
- Partial response, loss of response, frequent relapse, or residual functional impairment
- Adverse effects that limit dose optimization or adherence
- Polypharmacy with uncertain indication, benefit, or monitoring
- Diagnostic complexity, substance use, sleep disruption, or medical contributors
- Consideration of clozapine, esketamine, neuromodulation, or other specialty treatment
PMHNP priorities
- Confirm the diagnosis, current target symptoms, severity, function, safety, and level of care
- Reconstruct dose, duration, adherence, response, tolerability, and reasons each treatment changed
- Address access, cost, health literacy, substance use, sleep, medical illness, interactions, and patient preferences
- Use measurement-based follow-up and define what meaningful improvement would look like
- Review every medication for indication, benefit, risk, duplication, interactions, and monitoring needs
- Choose sequential, traceable changes and document the rationale, alternatives, and contingency plan
- Seek specialty consultation when treatment complexity, risk, monitoring, or clinician competence requires it
Care team
PMHNPs, psychiatrists, psychotherapists, pharmacists, primary care clinicians, nurses, laboratory and diagnostic services, sleep and substance-use specialists, interventional psychiatry teams, social workers, care coordinators, and patient-identified supports.